Reporting incidental findings of genomic disorder-associated copy number variants to unselected biobank participants

Procedural guidelines for disclosure of incidental genomic information are lacking. We introduce a method and evaluated the impact of returning results to population biobank participants with 16p11.2 copy number variants, which are commonly associated with neurodevelopmental disorders and BMI imbala...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Personalized medicine Jg. 13; H. 4; S. 303
Hauptverfasser: Leitsalu, Liis, Alavere, Helene, Jacquemont, Sébastien, Kolk, Anneli, Maillard, Anne M, Reigo, Anu, Nõukas, Margit, Reymond, Alexandre, Männik, Katrin, Ng, Pauline C, Metspalu, Andres
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England 01.07.2016
Schlagworte:
ISSN:1741-0541, 1744-828X, 1744-828X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Procedural guidelines for disclosure of incidental genomic information are lacking. We introduce a method and evaluated the impact of returning results to population biobank participants with 16p11.2 copy number variants, which are commonly associated with neurodevelopmental disorders and BMI imbalance. Of the 7877 participants, 11 carriers were detected. Eight participants were informed of their carrier status and surveyed 11-17 months later. All participants demonstrated preference for disclosure. Although two participants experienced worry, all five survey respondents rated receiving this information favorably. One participant reported modifications in treatment and three felt that their treatment/condition had since improved. This approach can be adapted and applied for the return of incidental findings to biobank participants.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1741-0541
1744-828X
1744-828X
DOI:10.2217/pme-2016-0009